1 Sept 2026
Mutant isocitrate dehydrogenase in cancer: Structural biology, small-molecule inhibitors, and future drug discovery strategiesPublisher siteDrug Discovery Today, Colorectal Cancer Treatments and Studies
UniversitiesMoataz A. Shaldam
Active, last published 2026
In synthesis and biological activity
Moataz A.
Shaldam
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Kafrelsheikh University
Claim Your Profile30
H-index
2.2k
Citations
Moataz has not officially claimed their profile. If you are Moataz, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
oataz A. Shaldam is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Moataz's work has been cited 2,247 times across 7 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×30Enzyme function and inhibition×17Bacterial biofilms and quorum sensing×16Synthesis and Catalytic Reactions×12Cancer therapeutics and mechanisms×10
04 · Where I am
Affiliations
Affiliation on published researchKafrelsheikh UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
77 works26 Jun 2026Open access
Salt-enhanced natural deep eutectic solvent microextraction: Eco-friendly tilmicosin detection in foodPublisher siteTalanta Open, Biosensors and Analytical Detection
28 May 2026
Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP‐1/EGFR InhibitorsPublisher siteDrug Development Research, PARP inhibition in cancer therapy
21 Feb 2026Open access
Exploring the impact of the innovative compound 3-(3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-5-(pyridin-3-yl)-1H-pyrazol-1-yl) indolin-2-one on accelerating wound recoveryPublisher siteScientific Reports, Wound Healing and Treatments
1 Jan 2026Open access
Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti- <i>Mycobacterium tuberculosis</i> agentsPublisher siteRSC Medicinal Chemistry, Antimicrobial agents and applications
16 Dec 2025
Piperidine-based small molecules as dual-stage antileishmanial agents targeting parasite folate pathwayPublisher siteBioorganic Chemistry
20 Nov 2025Open access
Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum CytotoxicityPublisher sitePharmaceuticals
7 Oct 20252cites
Identification of isatin-triazole-benzenesulfonamide hybrids as dual hCA IX/XII and c-met inhibitors with hypoxia-mediated chemo-sensitizing activityPublisher siteBioorganic Chemistry, Enzyme function and inhibition
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Moataz?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you